跳至主要内容
临床试验/NCT03216954
NCT03216954已完成早期 1 期

A Human Laboratory Study of n-Acetylcysteine for Alcohol Use Disorder

William Stoops1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2017年9月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Number of Alcohol Drinks Chosen

研究概览

简要总结

This study will evaluate the behavioral effects of alcohol during placebo and n-acetylcysteine maintenance using sophisticated human laboratory methods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • able to speak/read English
  • not seeking treatment at the time of the study
  • one binge drinking episode (5+/4+ standard alcoholic drinks per drinking session for men and women, respectively) in the past 30 days
  • recent alcohol use verified by ethyl glucuronide positive urine, as well as fulfillment of DSM-5 diagnostic criteria for alcohol use disorder
  • ECG within normal limits
  • otherwise healthy
  • body mass index of 19-35
  • females using an effective form of birth control and not pregnant or breast feeding
  • judged by the medical staff to be psychiatrically and physically healthy
  • able to abstain from alcohol for 12 hours prior to session
  • no contraindications/allergies to n-acetylcysteine

排除标准

  • 未提供

研究组 & 干预措施

Placebo

Placebo Comparator

Subjects will receive oral placebo capsules two times daily.

干预措施: Alcohol (Drug)

Placebo

Placebo Comparator

Subjects will receive oral placebo capsules two times daily.

干预措施: Placebos (Drug)

Low Dose n-Acetylcysteine

Experimental

Subjects will receive 0.6 g oral n-acetylcysteine two times daily.

干预措施: Alcohol (Drug)

Low Dose n-Acetylcysteine

Experimental

Subjects will receive 0.6 g oral n-acetylcysteine two times daily.

干预措施: N-acetyl cysteine (Drug)

High Dose n-Acetylcysteine

Experimental

Subjects will receive 1.2 g oral n-acetylcysteine two times daily.

干预措施: Alcohol (Drug)

High Dose n-Acetylcysteine

Experimental

Subjects will receive 1.2 g oral n-acetylcysteine two times daily.

干预措施: N-acetyl cysteine (Drug)

结局指标

主要结局

Number of Alcohol Drinks Chosen

时间窗: After at least four days of placebo or n-acetylcysteine maintenance

The reinforcing effects of alcohol were determined using a self-administration procedure in which subjects choose to take previously sampled doses. Reinforcing effects are measured during maintenance on placebo and n-acetylcysteine.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

William Stoops

Professor

University of Kentucky

研究点 (1)

Loading locations...

相似试验